Delivery Order SPE2DE24DA010-SPE2D626F3H8B

<p>The Defense Logistics Agency's Medical Supply Chain issued a $9,500 delivery order to Abbott Laboratories Inc. (Abbott Vascular Inc. division) on March 13, 2026, for cardiovascular medical devices and supplies.</p> <p>Place of performance is Santa Clara, CA. The order carries a fixed-price structure with economic price adjustment and has an ultimate completion date of March 19, 2026. No set-aside was used.</p>

<p>The Defense Logistics Agency Medical Supply Chain issued a $9,500 delivery order to Abbott Laboratories Inc. (Abbott Vascular Inc. division) on March 13, 2026, for cardiovascular medical devices and supplies, with ultimate completion by March 19, 2026.</p> <p>Place of performance is Santa Clara, CA. The order carries fixed-price pricing with economic price adjustment and no set-aside designation.</p>

<p>The Defense Logistics Agency's Medical Supply Chain issued a $9,500 delivery order to Abbott Laboratories Inc. (Abbott Vascular Inc. division) on March 10, 2026, for cardiovascular medical devices and related supplies with a fixed-price structure including economic price adjustment provisions.</p> <p>Place of performance is Santa Clara, CA. The order has an ultimate completion date of March 13, 2026. No set-aside was used.</p>

<p>The Defense Logistics Agency's Medical Supply Chain issued a $1,750 delivery order to Abbott Laboratories Inc. (Abbott Vascular Inc. division) on March 10, 2026, for cardiovascular medical devices and related supplies.</p> <p>Place of performance is Santa Clara, CA. The order carries a fixed-price structure with economic price adjustment and an ultimate completion date of March 13, 2026. No set-aside was used.</p>

<p>The Defense Logistics Agency Medical Supply Chain issued a $24,350 delivery order to Abbott Laboratories Inc. (Abbott Vascular Inc. division) on March 4, 2026, for cardiovascular medical devices and supplies.</p> <p>Place of performance is Santa Clara, CA. The order carries a fixed-price structure with economic price adjustment and has an ultimate completion date of March 9, 2026. No set-aside was used.</p>

<p>The Defense Logistics Agency Medical Supply Chain issued a $26,000 delivery order to Abbott Laboratories Inc. (Abbott Vascular Inc. division) on February 9, 2026, for medical device supply with an ultimate completion date of February 12, 2026.</p> <p>Place of performance is Santa Clara, CA 95054. The order carries a fixed-price structure with economic price adjustment provision and was issued under full and open competition with no set-aside designation.</p>

<p>The Defense Logistics Agency Medical Supply Chain issued a delivery order to Abbott Laboratories Inc. (Abbott Vascular Inc. division) on March 12, 2026, with a ceiling value of $25,715.85 for cardiac device implants (DFBR CRD THK12MM 51X69MM Gallant Impl 2).</p> <p>Place of performance is Santa Clara, CA. The order is fixed price with economic price adjustment and has an ultimate completion date of March 19, 2026. No set-aside was used.</p>

<p>The Defense Logistics Agency's Medical Supply Chain issued a $9,500 delivery order to Abbott Laboratories Inc. (Abbott Vascular Inc. division) on March 13, 2026, for cardiovascular medical devices and supplies with performance in Santa Clara, CA. The order carries a fixed-price structure with economic price adjustment and an ultimate completion date of March 24, 2026. No set-aside was used.</p>

<p>The Defense Logistics Agency's Medical Supply Chain issued a $34,971.95 delivery order to Abbott Laboratories Inc., Abbott Vascular Inc. division, on February 11, 2026, for cardiovascular medical devices and supplies with a fixed-price structure including economic price adjustment provisions.</p> <p>Place of performance is Santa Clara, CA 95054. The order ceiling value is $34,971.95, with an ultimate completion date of February 17, 2026. No set-aside was used for this award.</p>

<p>The Defense Logistics Agency's Medical Supply Chain issued a $9,500 delivery order to Abbott Laboratories Inc. (Abbott Vascular Inc. division) on March 5, 2026, with an ultimate completion date of March 10, 2026.</p> <p>Place of performance is Santa Clara, CA. The order carries fixed-price pricing with economic price adjustment. No set-aside was used.</p>